The Oncology Institute Inc (TOI) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket
 
The Oncology Institute Inc   (NASDAQ: TOI)
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare

Select the Financial Report: Select the Period:


Description of The Oncology Institute Inc's Business Segments


The Oncology Institute Inc. is a prominent healthcare organization that specializes in providing comprehensive cancer care services. As a leader in cancer treatment, it aims to offer patient-centered care through various segments, products, and services designed to support patients at every stage of their cancer journey. Below is an extensive overview of its key offerings.

1. Clinical Services
The Oncology Institute offers a range of clinical services focused on the diagnosis, treatment, and management of cancer. This includes:

- Medical Oncology: The organization provides chemotherapy, immunotherapy, targeted therapy, and hormonal treatments. Medical oncologists assess the patients condition and create individualized treatment plans.

- Radiation Oncology: Advanced radiation therapies, including intensity-modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT), and brachytherapy, are administered by trained radiation oncologists to target tumors effectively while minimizing damage to surrounding tissue.

- Surgical Oncology: Surgical interventions are performed by specialized surgeons who focus on cancer-related surgeries, including tumor resections and biopsies to diagnose or treat cancer.

- Palliative Care: Emphasizing quality of life, the palliative care teams work alongside oncologists to relieve symptoms and side effects associated with cancer treatments, providing support for pain management, psychological support, and emotional assistance.

Supportive Services
Apart from direct clinical care, The Oncology Institute also offers several supportive services that play a crucial role in the comprehensive treatment of cancer patients, including:

- Nutritional Counseling: Registered dietitians provide tailored nutritional plans that help patients manage their dietary needs during treatment, promoting health and recovery.

- Psychosocial Support: The organization employs social workers and counselors to provide emotional support, helping patients and their families cope with the challenges of a cancer diagnosis.

- Care Coordination: Dedicated care coordinators navigate the healthcare system for patients, assisting with appointment scheduling, insurance matters, and other logistical needs.

- Genetic Counseling: Genetic counselors help assess the risk factors, inheritance patterns, and implications of genetic testing for cancers, providing valuable information for decision-making regarding treatment and prevention.

Research and Clinical Trials
The Oncology Institute is actively involved in research and clinical trials, which are essential for advancing cancer treatment. This includes:

- Participating in Clinical Trials: Patients are often given the opportunity to participate in clinical trials aimed at testing new therapies or treatment combinations, contributing to scientific research and finding innovative solutions for cancer care.

- Research Collaborations: The organization collaborates with universities and research institutions to develop cutting-edge cancer therapies and enhance the understanding of cancer biology.

Patient Education
Education is a vital part of the treatment process at The Oncology Institute. They provide resources to help patients understand their diagnosis and treatment options better, including:

- Workshops and Seminars: Regular events are organized to educate patients and their families about cancer types, treatment options, and coping strategies.

- Educational Materials: Comprehensive brochures, guides, and online resources are available to provide patients with information about their diagnoses, general cancer education, and disease management.

Telehealth Services
Telehealth has been integrated into The Oncology Institute’s service offerings to enhance accessibility and convenience for patients. This includes:

- Virtual Consultations: Patients can have follow-up appointments and consultations through secure video conferencing, allowing them to receive care from the comfort of their homes.

- Remote Monitoring: Some patients may have access to remote monitoring tools to track their symptoms and treatment side effects, ensuring timely interventions if issues arise.

Community Outreach and Screening Programs
The Oncology Institute is committed to community health and often engages in outreach programs to raise awareness about cancer prevention and early detection. This can include:

- Screening Events: Organizing free or low-cost cancer screening events to increase awareness and facilitate early detection, particularly in underserved communities.

- Educational Campaigns: Collaborating with local organizations to disseminate information regarding risk factors, the importance of screenings, and lifestyle changes to prevent cancer.

Technology and Innovation
Investment in advanced technology is a critical focus area for The Oncology Institute, which enhances their diagnostic and treatment capabilities. This includes:

- Innovative Treatment Techniques: Utilizing the latest advancements, such as personalized medicine and biomarkers, to tailor treatments according to individual patient characteristics.

- Electronic Health Records (EHR): Implementing sophisticated EHR systems to streamline patient information management, enhance care coordination, and support data-driven decision making.

Summary
The Oncology Institute Inc. provides a comprehensive suite of services aimed at delivering exceptional cancer care. Its commitment to clinical excellence, patient support, research, and community engagement highlights its role as a critical player in the oncology landscape. By addressing the multifaceted needs of cancer patients and focusing on innovative treatments, the organization strives to improve outcomes and enhance the quality of life for patients battling cancer.


Composition of The Oncology Institute Inc Revenues by Segments

 
Patient services    40.08 % of total Revenue
Capitated revenue    18.27 % of total Revenue
FFS revenue    21.81 % of total Revenue
Specialty pharmacy revenue    59.37 % of total Revenue
Clinical research trials and other revenue    0.55 % of total Revenue
segments    100 % of total Revenue
Patient services segments    40.08 % of total Revenue
Specialty pharmacy segments    59.37 % of total Revenue
Clinical trials other segments    0.55 % of total Revenue

Q1 three months ended (Mar 31 2026)
Revenues by Business Segments Revenues
(in millions $)
%
(of total Revenues)
Patient services 59.09 40.08 %
Capitated revenue 26.93 18.27 %
FFS revenue 32.16 21.81 %
Specialty pharmacy revenue 87.54 59.37 %
Clinical research trials and other revenue 0.81 0.55 %
segments 147.44 100 %
Patient services segments 59.09 40.08 %
Specialty pharmacy segments 87.54 59.37 %
Clinical trials other segments 0.81 0.55 %
Total 147.44 100 %




Q1 three months ended (Mar 31 2026)
Revenue Growth rates by Segment Y/Y Revenue
%
Q/Q Revenue
%
Patient services 11.34 % -
Capitated revenue 53.94 % -
FFS revenue -9.61 % -
Specialty pharmacy revenue 77.59 % -
Clinical research trials and other revenue -60.24 % -
segments 41.22 % -
Patient services segments 11.34 % -
Specialty pharmacy segments 77.59 % -
Clinical trials other segments -60.24 % -
Total 41.22 % -70.67 %




Q1 three months ended (Mar 31 2026)
Income by Business Segments Income
(in millions $)
%
(Profit Margin)
Total -2.09 -




Q1 three months ended (Mar 31 2026)
Income Growth rates by Segment Y/Y Income
%
Q/Q Income
%
Total - -




Annual Report on The Oncology Institute Inc Divisions, Sales by Country

 
Patient services   Patient services Segment contribution to total sales 45.55 % of total Revenue
Capitated revenue   Capitated revenue Segment contribution to total sales 16.01 % of total Revenue
FFS revenue   FFS revenue Segment contribution to total sales 29.54 % of total Revenue
Clinical research trials and other revenue   Clinical research trials and other revenue Segment contribution to total sales 0.91 % of total Revenue
segments   segments Segment contribution to total sales 100 % of total Revenue
Specialty pharmacy   Specialty pharmacy Segment contribution to total sales 53.54 % of total Revenue
Clinical trials other   Clinical trials other Segment contribution to total sales 0.91 % of total Revenue


Twelve months ended 2025
TOI s Annual Revenue by Geography and Business Segments Sales
(in millions $)
%
(of total Sales)
Patient services 228.99 45.55 %
Capitated revenue 80.48 16.01 %
FFS revenue 148.51 29.54 %
Clinical research trials and other revenue 4.56 0.91 %
segments 502.73 100 %
Total 502.73 100 %
Specialty pharmacy 269.18 53.54 %
Clinical trials other 4.56 0.91 %


Twelve months ended 2025
TOI s Annual Income by Country and Business Segments Income
(in millions $)
%
(Profit Margin)
Total -50.31 -

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
Patient services 11.77 % -
Capitated revenue 17.17 % -
FFS revenue 9.04 % -
Clinical research trials and other revenue -47.03 % -
segments 27.79 % -
Total 27.79 % -
Dispensary revenue - -
Specialty pharmacy 49.61 % -
Clinical trials other -47.03 % -
Dispensary - -



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.